Atlas Trials

A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)

Clinical trial NCT03665038 · COMPLETED

Trial details

NCT number
NCT03665038
Sponsor
Supernus Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Post Partum Depression
Start date
2018-09-07
Primary completion
2021-01-08
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.